Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep423 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Semaglutide therapy in people with type 2 diabetes and obesity: efficacy on glycated hemoglobin and weight loss

Del Prete Michela , Eugenia Disoteo Olga , Cozzi Renato , Di Sacco Gianleone , Vignati Federico , Gavazzi Lidia , Muratori Fabrizio

Introduction: The long acting GLP-1 analogue, Semaglutide (S), is indicated for the treatment of adults with type 2 diabetes mellitus (T2DM). Since November 2021, S has also been approved by the European Medicines Agency (EMA) at a dose of 2.4 mg for the treatment of obesity. Here, we report the efficacy of S, either alone or in combination with other antidiabetic drugs, in patients with T2DM and obesity on glycated hemoglobin (HBA1C) and weight loss.Pat...

ea0081ep646 | Pituitary and Neuroendocrinology | ECE2022

A clinical case of hypogonadism and anosmia associated with a new mutation of the KAL1/ANOS1 gene: a preliminary report

Del Prete Michela , Sacco Gianleone Di , Bonomi Marco , Vignati Federico , Muratori Fabrizio , Persani Luca

Introduction: Kallmann syndrome (KS) is a genetic condition characterized by the association of anosmia or hyposmia and GnRH deficiency resulting in congenital hypogonadotropic hypogonadism (CHH). Different genes can be implicated in KS, and the most frequent allelic variant occurs in the KAL1/ANOS1 gene in the X-linked form. Differential diagnosis is often made with other rare genetic diseases as CHARGE syndrome (CS) that includes hypogonadism, hyposmia and several organ defe...

ea0050n2.3 | Nurse Session 2: Diabetes Insipidus | SFEBES2017

Challenging cases in DI

Ball Stephen

Diabetes Insipidus (DI) results from a relative or absolute deficiency in either the production or action of the posterior pituitary hormone Vasopressin (AVP), the principle endocrine regulator of renal water excretion. The challenges in DI encompass its diagnosis, its treatment and in managing the co-morbidities and complications of the condition. This presentation will cover all these elements, highlighting cases that illustrate some of the key principles in the clinical app...

ea0050n2.3 | Nurse Session 2: Diabetes Insipidus | SFEBES2017

Challenging cases in DI

Ball Stephen

Diabetes Insipidus (DI) results from a relative or absolute deficiency in either the production or action of the posterior pituitary hormone Vasopressin (AVP), the principle endocrine regulator of renal water excretion. The challenges in DI encompass its diagnosis, its treatment and in managing the co-morbidities and complications of the condition. This presentation will cover all these elements, highlighting cases that illustrate some of the key principles in the clinical app...

ea0015p254 | Pituitary | SFEBES2008

Early polyuria and diabetes insipidus (DI) following transsphenoidal surgery and their relationship to chronic DI

Gupta Rajesh , Bhatt Sonia , Bullock PM , McGregor AM , Thomas NW , Aylwin SJB

Background and aims: Diabetes insipidus (DI) is a common complication after transsphenoidal surgery (TSS), but resolves in the majority of patients. We determined the osmolalities and timing of DI most that best predicted long-term outcome.Methods: Case series study randomly including 54 patients out of total 99 patients who underwent transsphenoidal surgery over 18 months. Follow up information was ascertained from clinic review or by telephone intervie...

ea0055wa9 | Workshop A: Disorders of the hypothalamus and pituitary (I) | SFEEU2018

Acute onset DI in a young woman

Pittaway James , Drake William

A 31 year-old lady presented to clinic with an acute, three-week history of rapidly worsening polyuria and polydipsia. She described an eighteen month history of dysmenorrhoea with no galactorrhoea and reported no change in her vision. Her past medical history included alopecia areata one year previously from which she made a full recovery. Clinical examination was normal including full visual fields to red-pin confrontation. Biochemistry identified serum sodium of 141 mmol/l,...

ea0025p46 | Clinical biochemistry | SFEBES2011

A case of Di George’s syndrome presenting in late adulthood

Brewster Sarah , Rajendran Rajesh , Coppini David , Richardson Tristan

Introduction: Di George’s syndrome is a rare congenital disease that is usually diagnosed in childhood due to its presentation with velo-cardio-facial abnormalities.Case report: A 42-year-old man was incidentally found to be hypocalcaemic (corrected calcium 1.71 mmol/l) during a ‘well-man check’. A subsequent parathyroid hormone (PTH) was inappropriately low at 0.8 pmol/l (reference range 0.5–4.4 pmol/l).He was ...

ea0013p45 | Clinical practice/governance and case reports | SFEBES2007

Di-George syndrome presenting as hypocalcaemia in adulthood

Hunter Steven , Johnston Philip , Morrison Patrick

A 29 year old female presented with a two year history of recurrent numbness and tingling in her hands. Trousseau’s sign was positive. Investigations confirmed hypocalcaemia with serum calcium 1.64 nmol/L (2.10–2.60), phosphate 1.23 nmol/L (0.80–1.55), alkaline phosphatase 82 U/L (35–120). Parathyroid hormone was inappropriately normal at 36 pg/ml (10–65), Vitamin D 78 nmol/L (50–75). Her mother reported a history of hypocalcaemia when she was two...

ea0063p251 | Pituitary and Neuroendocrinology 1 | ECE2019

Primary infundibulohypophysitis in a young man with DI and Hypogonadism

Ilie Iuliana , Musat Madalina , Hortopan Dan , Iordachescu Carmen , Mitrea Dan , Banica Andreea , Oprea Luciana

Primary hypophysitis is a rare inflammatory condition which is mostly encountered in women. It represents 0.2–0.8% of pituitary pathologies and its annual incidence is estimated at 1 case per 9 million inhabitants. We present the case of a 28-year-old male, smoker, with sudden onset decreased libido, polyuria and polydipsia. At presentation he had an epicranial lipoma with and no other suggestive clinical signs. Biochemistry revealed hypernatremia 146 nmol/L, low testoste...

ea0065p145 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer | SFEBES2019

DI patients vote for a name change to pituitary insipidus to improve safety – a survey

Prentice Malcolm

Aims: To discover the views of patients with Diabetes Insipidus (DI) on difficulties they encounter with managing DI in different circumstances; the possible causes of these difficulties and how these might be improved for their safety.Background: Between 2009 and 2015 there were 471 serious adverse inpatient incidents and 2 deaths involving DDAVP administration1. The analysis of one death resulted in a suggestion that the name of the conditio...